BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 15578920)

  • 21. The role of STATs in apoptosis.
    Battle TE; Frank DA
    Curr Mol Med; 2002 Jun; 2(4):381-92. PubMed ID: 12108949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral but not central axotomy induces changes in Janus kinases (JAK) and signal transducers and activators of transcription (STAT).
    Schwaiger FW; Hager G; Schmitt AB; Horvat A; Hager G; Streif R; Spitzer C; Gamal S; Breuer S; Brook GA; Nacimiento W; Kreutzberg GW
    Eur J Neurosci; 2000 Apr; 12(4):1165-76. PubMed ID: 10762348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells.
    Spiekermann K; Pau M; Schwab R; Schmieja K; Franzrahe S; Hiddemann W
    Exp Hematol; 2002 Mar; 30(3):262-71. PubMed ID: 11882364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-mediated activation of the STAT signaling pathway in a human carcinoid tumor.
    Wang S; Tyring SK; Townsend CM; Evers BM
    Ann Surg Oncol; 1998; 5(7):642-9. PubMed ID: 9831114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of STAT proteins and growth control.
    Bromberg JF
    Bioessays; 2001 Feb; 23(2):161-9. PubMed ID: 11169589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
    Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR
    Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STATs in oncogenesis.
    Bowman T; Garcia R; Turkson J; Jove R
    Oncogene; 2000 May; 19(21):2474-88. PubMed ID: 10851046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STAT signaling in the pathogenesis and treatment of cancer.
    Frank DA
    Mol Med; 1999 Jul; 5(7):432-56. PubMed ID: 10449805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.
    Ebong S; Chepelinsky AB; Robinson ML; Zhao H; Yu CR; Egwuagu CE
    Mol Vis; 2004 Feb; 10():122-31. PubMed ID: 14978477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JAK/STAT-dependent gene regulation by cytokines.
    Hebenstreit D; Horejs-Hoeck J; Duschl A
    Drug News Perspect; 2005 May; 18(4):243-9. PubMed ID: 16034480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the Jak/STAT signaling pathway prevents the high glucose-induced increase in tgf-beta and fibronectin synthesis in mesangial cells.
    Wang X; Shaw S; Amiri F; Eaton DC; Marrero MB
    Diabetes; 2002 Dec; 51(12):3505-9. PubMed ID: 12453907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer.
    Mali SB
    Oral Oncol; 2015 Jun; 51(6):565-9. PubMed ID: 25817923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STAT proteins and transcriptional responses to extracellular signals.
    Horvath CM
    Trends Biochem Sci; 2000 Oct; 25(10):496-502. PubMed ID: 11050435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activating mutations in STAT3 and STAT5 differentially affect cellular proliferation and apoptotic resistance in multiple myeloma cells.
    Hodge DR; Xiao W; Wang LH; Li D; Farrar WL
    Cancer Biol Ther; 2004 Feb; 3(2):188-94. PubMed ID: 14726660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer.
    Haura EB; Turkson J; Jove R
    Nat Clin Pract Oncol; 2005 Jun; 2(6):315-24. PubMed ID: 16264989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus.
    Chen H; Hutt-Fletcher L; Cao L; Hayward SD
    J Virol; 2003 Apr; 77(7):4139-48. PubMed ID: 12634372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
    Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
    Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
    Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
    Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Stat family in cytokine signaling.
    Ihle JN
    Curr Opin Cell Biol; 2001 Apr; 13(2):211-7. PubMed ID: 11248555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
    Chen CW; Chang YH; Tsi CJ; Lin WW
    J Immunol; 2003 Jul; 171(2):979-88. PubMed ID: 12847270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.